drugset / Trial / NCT04351620
High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19
NaSingle-groupOpen-labelTreatment
Summary
This study aims to examine the tolerability of high dose hydroxychloroquine in patients with COVID-19 who are not yet hospitalized, but have risk factors for disease progression and complications.
Timeline
- Start
- 2020-04-20
- Primary completion
- 2020-06-10
- Completion
- 2020-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 1200 mg | — |